Search Results - "Heyes, M P"
-
1
Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease
Published in Brain (London, England : 1878) (01-10-1992)“…Neurological dysfunction, seizures and brain atrophy occur in a broad spectrum of acute and chronic neurological diseases. In certain instances,…”
Get more information
Journal Article -
2
Glutamate is a mediator of neurotoxicity in secretions of activated HIV-1-infected macrophages
Published in Journal of neuroimmunology (02-07-2001)“…We sought to identify neurotoxin(s) secreted by HIV-1-infected mononuclear phagocytes that could contribute to the pathophysiology of HIV-1-associated dementia…”
Get full text
Journal Article -
3
Human macrophages convert L-tryptophan into the neurotoxin quinolinic acid
Published in Biochemical journal (01-05-1992)“…Substantial increases in the concentrations of the excitotoxin and N-methyl-D-aspartate-receptor agonist quinolinic acid (QUIN) occur in human patients and…”
Get full text
Journal Article -
4
A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate
Published in Brain (London, England : 1878) (01-12-1993)“…Quinolinic acid (QUIN), kynurenic acid (KYNA) and L-kynurenine (L-KYN) are neuroactive kynurenine pathway metabolites that accumulate in inflammatory…”
Get more information
Journal Article -
5
Elevated cerebrospinal fluid quinolinic acid levels are associated with region-specific cerebral volume loss in HIV infection
Published in Brain (London, England : 1878) (01-05-2001)“…Neuronal injury, dendritic loss and brain atrophy are frequent complications of infection with human immunodeficiency virus (HIV) type 1. Activated brain…”
Get full text
Journal Article -
6
Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse
Published in Neuroscience (01-11-1992)“…Accumulation of quinolinic acid and neuroactive kynurenines derived from tryptophan are of potential significance in human neuropathologic diseases because of…”
Get more information
Journal Article -
7
A mechanism for increased quinolinic acid formation following acute systemic immune stimulation
Published in The Journal of biological chemistry (25-07-1993)“…Mechanisms for increased levels of quinolinic acid (QUIN) following systemic immune stimulation were investigated. In gerbils, systemic administration of…”
Get full text
Journal Article -
8
Quantitation of human immunodeficiency virus, immune activation factors, and quinolinic acid in AIDS brains
Published in The Journal of clinical investigation (01-06-1993)“…HIV encephalitis is unusual in that neurologic damage occurs in the absence of significant infection of neuronal or glial cells. Because the predominant…”
Get full text
Journal Article -
9
Effects of methylprednisolone and 4-chloro-3-hydroxyanthranilic acid in experimental spinal cord injury in the guinea pig appear to be mediated by different and potentially complementary mechanisms
Published in Spinal cord (01-09-2014)“…Study design: Blinded, placebo-controlled, parallel treatment group studies of the effects of methylprednisolone (MP) or 4-chloro-3-hydroxyanthranilate…”
Get full text
Journal Article -
10
Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status
Published in Annals of neurology (01-02-1991)“…Quinolinic acid is an "excitotoxic" metabolite and an agonist of N-methyl-D-aspartate receptors. Of patients infected with human immunodeficiency virus type 1…”
Get more information
Journal Article -
11
4-chloro-3-hydroxyanthranilate, 6-chlorotryptophan and norharmane attenuate quinolinic acid formation by interferon-γ-stimulated monocytes (THP-1 cells)
Published in Biochemical journal (01-04-1993)“…Accumulation of quinolinic acid and L-kynurenine occurs in the brain and/or blood following immune activation, and may derive from L-tryptophan following…”
Get full text
Journal Article -
12
Prospective study of neurological responses to treatment with macrophage-targeted glucocerebrosidase in patients with type 3 Gaucher's disease
Published in Annals of neurology (01-10-1997)“…We prospectively evaluated the clinical and biochemical responses to enzyme-replacement therapy (ERT) with macrophage-targeted glucocerebrosidase (Ceredase)…”
Get more information
Journal Article -
13
Quantification of Local De Novo Synthesis Versus Blood Contributions to Quinolinic Acid Concentrations in Brain and Systemic Tissues
Published in Journal of neurochemistry (01-01-1997)“…: The source of the neurotoxin quinolinic acid (QUIN) in brain and systemic tissues under normal and pathologic circumstances reflects either de novo synthesis…”
Get full text
Journal Article -
14
Early intrathecal events in rhesus macaques (Macaca mulatta) infected with pathogenic or nonpathogenic molecular clones of simian immunodeficiency virus
Published in Laboratory investigation (01-05-1995)“…Encephalitis is a common and devastating sequela of HIV infection in humans and of simian immunodeficiency virus (SIV) infection in rhesus macaques. We used…”
Get more information
Journal Article -
15
Metabolism and neuropathologic significance of quinolinic acid and kynurenic acid
Published in Biochemical Society transactions (01-02-1993)Get more information
Journal Article -
16
Quinolinic Acid In Vivo Synthesis Rates, Extracellular Concentrations, and Intercompartmental Distributions in Normal and Immune‐Activated Brain as Determined by Multiple‐Isotope Microdialysis
Published in Journal of neurochemistry (01-01-1998)“…: Quinolinic acid (QUIN) kills neurons by activation of NMDA receptors that are accessed via the extracellular fluid (ECF). In vivo microdialysis was employed…”
Get full text
Journal Article -
17
Mechanism of delayed increases in kynurenine pathway metabolism in damaged brain regions following transient cerebral ischemia
Published in Journal of neurochemistry (01-01-1993)“…Delayed increases in the levels of an endogenous N-methyl-D-aspartate receptor agonist, quinolinic acid (QUIN), have been demonstrated following transient…”
Get more information
Journal Article -
18
Neuroactive kynurenines in Lyme borreliosis
Published in Neurology (1992)“…Although neurologic dysfunction occurs frequently in patients with Lyme borreliosis, it is rarely possible to demonstrate the causative organism within the…”
Get full text
Journal Article -
19
Quinolinic acid is increased in CSF and associated with mortality after traumatic brain injury in humans
Published in Journal of cerebral blood flow and metabolism (01-06-1998)“…We tested the hypothesis that quinolinic acid, a tryptophan-derived N-methyl-D-aspartate agonist produced by macrophages and microglia, would be increased in…”
Get more information
Journal Article -
20
Conditioned Immune Response to Interferon-γ in Humans
Published in Clinical immunology (Orlando, Fla.) (01-02-1999)“…We determined whether a classical conditioning paradigm may be used to condition immunologic responses in normal human subjects receiving an optimal…”
Get full text
Journal Article